PL2666872T3 - Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek - Google Patents
Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerekInfo
- Publication number
- PL2666872T3 PL2666872T3 PL13177829.2T PL13177829T PL2666872T3 PL 2666872 T3 PL2666872 T3 PL 2666872T3 PL 13177829 T PL13177829 T PL 13177829T PL 2666872 T3 PL2666872 T3 PL 2666872T3
- Authority
- PL
- Poland
- Prior art keywords
- renal
- prognosis
- diagnosis
- compositions
- methods
- Prior art date
Links
- 208000001647 Renal Insufficiency Diseases 0.000 title 1
- 206010061481 Renal injury Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 201000006370 kidney failure Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/521—Chemokines
- G01N2333/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4 or KC
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96447—Factor VII (3.4.21.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30202510P | 2010-02-05 | 2010-02-05 | |
| US30202110P | 2010-02-05 | 2010-02-05 | |
| US30203610P | 2010-02-05 | 2010-02-05 | |
| US30202710P | 2010-02-05 | 2010-02-05 | |
| US30202610P | 2010-02-05 | 2010-02-05 | |
| US37406010P | 2010-08-16 | 2010-08-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2666872T3 true PL2666872T3 (pl) | 2016-10-31 |
Family
ID=44355818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13177829.2T PL2666872T3 (pl) | 2010-02-05 | 2011-02-04 | Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US11454635B2 (enExample) |
| EP (2) | EP2531620B1 (enExample) |
| JP (3) | JP2013519095A (enExample) |
| KR (1) | KR101940014B1 (enExample) |
| CN (2) | CN105158481A (enExample) |
| AU (1) | AU2011213684B2 (enExample) |
| BR (1) | BR112012019542A2 (enExample) |
| CA (1) | CA2788826C (enExample) |
| CY (1) | CY1117784T1 (enExample) |
| DK (1) | DK2666872T3 (enExample) |
| EA (1) | EA201290629A1 (enExample) |
| ES (1) | ES2585184T3 (enExample) |
| HK (1) | HK1212764A1 (enExample) |
| HR (1) | HRP20160733T1 (enExample) |
| HU (1) | HUE029304T2 (enExample) |
| MX (2) | MX366653B (enExample) |
| NZ (2) | NZ601590A (enExample) |
| PL (1) | PL2666872T3 (enExample) |
| PT (1) | PT2666872T (enExample) |
| RS (1) | RS54879B1 (enExample) |
| SI (1) | SI2666872T1 (enExample) |
| SM (1) | SMT201600245B (enExample) |
| WO (1) | WO2011097539A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ628843A (en) | 2008-10-21 | 2016-02-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JP5763098B2 (ja) | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| DK2666872T3 (en) * | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
| WO2011162821A1 (en) | 2010-06-23 | 2011-12-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2013086359A1 (en) | 2011-12-08 | 2013-06-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US20150293131A1 (en) | 2012-04-02 | 2015-10-15 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of sepsis |
| CA3158996C (en) * | 2013-01-17 | 2024-06-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| HK1219129A1 (zh) * | 2013-01-29 | 2017-03-24 | 阿斯图特医药公司 | 用於肾损伤和肾衰竭的诊断及预後的方法和组合物 |
| US20160146832A1 (en) | 2013-06-05 | 2016-05-26 | Lakhmir S. Chawla | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| MX375701B (es) | 2013-11-06 | 2025-03-06 | Astute Medical Inc | Ensayos para igfbp7 con mejor rendimiento en muestras biológicas. |
| CN105917229B (zh) | 2013-12-03 | 2019-04-26 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| MX388231B (es) | 2014-10-20 | 2025-03-19 | Astute Medical Inc | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. |
| WO2016164854A1 (en) | 2015-04-09 | 2016-10-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN108139409B (zh) * | 2015-10-08 | 2020-07-24 | 豪夫迈·罗氏有限公司 | 当在外科手术之前测量时用于预测aki的风险的igfbp7 |
| JP7080176B2 (ja) | 2016-02-29 | 2022-06-03 | エフ．ホフマン－ラ ロシュ アーゲー | 子癇前症におけるマーカーとしてのｉｇｆｂｐ－７ |
| AU2017277305A1 (en) | 2016-06-06 | 2018-12-20 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
| EP4063853A1 (en) | 2017-01-12 | 2022-09-28 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
| US11346846B2 (en) | 2017-02-06 | 2022-05-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN110709103B (zh) | 2017-04-05 | 2024-02-02 | 机敏医药股份有限公司 | 用于生物学样品中具有改善的性能的timp2的测定法 |
| EP3824291A1 (en) | 2018-07-20 | 2021-05-26 | Roche Diagnostics GmbH | Prediction of preeclampsia based on igfbp-7 |
| KR102388887B1 (ko) | 2018-11-16 | 2022-04-21 | 서울대학교병원 | 비심장 수술 후 급성 신부전 발생 위험도 예측 시스템 및 방법 |
| CN112635049A (zh) * | 2020-12-23 | 2021-04-09 | 无锡市第二人民医院 | 一种研究HSD17B13 rs72613567基因变异和肾功能损伤之间关系的方法 |
| CN113892931B (zh) * | 2021-10-14 | 2023-08-22 | 重庆大学 | 一种基于深度学习的fmcw雷达提取分析腹内压力方法 |
| KR20230160511A (ko) | 2022-05-17 | 2023-11-24 | 경북대학교 산학협력단 | 호중구 젤라티나제 리포칼린과 특이적으로 결합하는 펩타이드 및 이의 용도 |
Family Cites Families (128)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1429031A1 (ru) | 1986-06-20 | 1988-10-07 | Калининский Государственный Медицинский Институт | Способ дифференциальной диагностики гломерулонефрита и пиелонефрита |
| US5118614A (en) * | 1988-01-18 | 1992-06-02 | Tessek Sdruzeni Praha | Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
| WO1997044460A1 (en) | 1996-05-24 | 1997-11-27 | Biogen, Inc. | Modulators of tissue regeneration |
| US5753455A (en) | 1996-09-03 | 1998-05-19 | Bayer Corporation | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| EP0984984A2 (en) | 1997-06-03 | 2000-03-15 | Sagami Chemical Research Center | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| US20060223077A1 (en) | 1997-06-06 | 2006-10-05 | Human Genome Sciences, Inc. | 207 human secreted proteins |
| US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
| WO2000036105A1 (en) * | 1998-12-18 | 2000-06-22 | Human Genome Sciences, Inc. | Prostacyclin-stimulating factor-2 |
| US6709855B1 (en) * | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
| AU1674400A (en) | 1998-12-21 | 2000-07-12 | Monash University | Kidney disease detection and treatment |
| EP1295939A4 (en) | 2000-06-15 | 2005-02-02 | Kyowa Hakko Kogyo Kk | INSULIN SIMILAR GROWTH FACTOR BINDING PROTEIN |
| RU2180965C1 (ru) | 2000-07-03 | 2002-03-27 | Габбасова Наталья Вадимовна | Способ дифференциальной диагностики заболеваний почек |
| EP1405072A2 (en) | 2000-12-29 | 2004-04-07 | Oxford GlycoSciences (UK) Limited | Proteins, genes and their use for diagnosis and treatment of kidney response |
| US20060088823A1 (en) | 2001-03-29 | 2006-04-27 | Brian Haab | Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification |
| US20070015146A1 (en) | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US20030003588A1 (en) | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
| BR0211468A (pt) | 2001-07-24 | 2004-11-23 | Univ Yale | Métodos de tratar e de prevenir uma doença inflamátoria em um mamìfero e de identificar um composto útil para tratar uma doença inflamatória em um mamìfero, composto, e kits para tratar e para prevenir uma doença inflamatória em um mamìfero |
| US6784154B2 (en) | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
| US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
| GB0130557D0 (en) * | 2001-12-20 | 2002-02-06 | Serono Internat S A | Proteins |
| US20070233391A1 (en) | 2002-03-07 | 2007-10-04 | Cambridge University Technical Service Limited (CUTS) | Scd fingerprints |
| AU2003214604A1 (en) | 2002-03-21 | 2003-10-08 | Hadasit Medical Research Services And Development Ltd. | Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same |
| US7138230B2 (en) * | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
| US7138229B2 (en) | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
| WO2004005934A2 (en) | 2002-07-04 | 2004-01-15 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
| US6941172B2 (en) | 2002-11-18 | 2005-09-06 | Zvi Nachum | Method and device for restoring kidney function using electromagnetic stimulation |
| AU2003300823A1 (en) | 2002-12-06 | 2004-06-30 | Sandia Corporation | Outcome prediction and risk classification in childhood leukemia |
| WO2004059293A2 (en) * | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| CN1791797A (zh) | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
| AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
| US7560244B2 (en) | 2003-06-04 | 2009-07-14 | Joslin Diabetes Center, Inc. | Method of evaluating a subject for risk or predisposition of reduced renal function over time |
| WO2005010213A2 (en) * | 2003-07-17 | 2005-02-03 | Pacific Edge Biotechnology, Ltd. | Markers for detection of gastric cancer |
| US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
| EP1727564A1 (en) | 2004-03-17 | 2006-12-06 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
| WO2005103281A2 (en) | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US7588892B2 (en) | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
| WO2006008661A2 (en) | 2004-07-19 | 2006-01-26 | Neurochem (International) Limited | Diagnostic methods of multiple organ amyloidosis |
| US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
| CA2596469A1 (en) | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of H Ealth & Human Services | Biomarkers for tissue status |
| JP2008537875A (ja) | 2005-03-14 | 2008-10-02 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物 |
| US7608413B1 (en) | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
| US20070037232A1 (en) | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
| WO2006111029A1 (en) | 2005-04-18 | 2006-10-26 | Genesis Genomics Inc. | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| US20070087387A1 (en) * | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
| CN102875681A (zh) * | 2005-07-08 | 2013-01-16 | 拜奥根Idec马萨诸塞公司 | 抗-αvβ6抗体及其用途 |
| US7833732B2 (en) | 2005-07-21 | 2010-11-16 | The John Hopkins University | Acute renal injury |
| US7759077B2 (en) | 2005-08-02 | 2010-07-20 | Shariat Shahrokh F | Soluble fas urinary marker for the detection of bladder transitional cell carcinoma |
| TWI323734B (en) * | 2005-08-19 | 2010-04-21 | Abbott Lab | Dual variable domain immunoglobulin and uses thereof |
| EP1757940A1 (en) | 2005-08-26 | 2007-02-28 | Cézanne S.A.S. | In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC |
| CA2624569A1 (en) | 2005-10-03 | 2007-04-12 | Biosite Incorporated | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| US20080090304A1 (en) | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
| US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
| US10716749B2 (en) | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
| US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| TW200726845A (en) | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
| GB0605217D0 (en) | 2006-03-15 | 2006-04-26 | Novartis Ag | Method and compositions for assessing acute rejection |
| GB0606776D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
| US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
| US20080038269A1 (en) | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
| US20080118924A1 (en) * | 2006-05-26 | 2008-05-22 | Buechler Kenneth F | Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
| WO2008084331A2 (en) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
| US20090298073A1 (en) | 2006-06-30 | 2009-12-03 | Gerhold David L | Kidney Toxicity Biomarkers |
| WO2008009132A1 (en) | 2006-07-21 | 2008-01-24 | The Governors Of The University Of Alberta | Tissue rejection |
| GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
| US20080206794A1 (en) | 2006-09-15 | 2008-08-28 | Renovar Incorporated | Systems And Methods For Characterizing Contrast Induced-Nephropathy |
| EP2095107B1 (en) | 2006-11-14 | 2014-07-02 | Alere San Diego, Inc. | Methods for risk assignment |
| WO2008073899A2 (en) | 2006-12-08 | 2008-06-19 | The Children's Hospital Of Philadelphia | Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis |
| GB0701626D0 (en) | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
| PL2115477T3 (pl) | 2007-01-25 | 2015-12-31 | Hoffmann La Roche | Zastosowanie IGFBP-7 do oceny niewydolności serca |
| WO2008104803A2 (en) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Proteins |
| US8221995B2 (en) | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| EP2479568B1 (en) | 2007-03-26 | 2015-01-07 | Novartis AG | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| EP2134866A2 (en) | 2007-04-10 | 2009-12-23 | Integragen | Human diabetes susceptibility tnfrsf10b gene |
| US8080394B2 (en) | 2007-04-27 | 2011-12-20 | Brigham And Women's Hospital | Method for determining predisposition to pulmonary infection |
| WO2008150488A1 (en) | 2007-06-01 | 2008-12-11 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
| JP5661457B2 (ja) | 2007-06-06 | 2015-01-28 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | 腎疾患の予測診断 |
| US20090047689A1 (en) | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
| EP2019318A1 (en) | 2007-07-27 | 2009-01-28 | Erasmus University Medical Center Rotterdam | Protein markers for cardiovascular events |
| WO2009036188A2 (en) * | 2007-09-11 | 2009-03-19 | University Of Massachusetts | Insulin-like growth factor binding protein 7 for treatment of cancer |
| US20100267041A1 (en) | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
| US8039227B2 (en) | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
| US20110059537A1 (en) | 2007-09-20 | 2011-03-10 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for estimating risk of acute kidney injury |
| US8003333B2 (en) | 2007-09-28 | 2011-08-23 | Mayo Foundation For Medical Education And Research | Serum biomarkers for early detection of acute cellular rejection |
| BRPI0820793A2 (pt) * | 2007-12-10 | 2015-06-16 | Hoffmann La Roche | Seprase como marcador de câncer |
| KR20100122495A (ko) | 2008-02-29 | 2010-11-22 | 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 | 급성 신장 장해 및 예후 추정용 바이오마커 및 그 용도 |
| US20110104700A1 (en) * | 2008-05-30 | 2011-05-05 | Halloran Philip F | Molecular signature for fibrosis and atrophy |
| WO2009146450A2 (en) | 2008-05-30 | 2009-12-03 | Therapeutic Monitoring Services, L.L.C. | Methods for monitoring immunosuppressant drug levels, renal function, and hepatic function using small volume samples |
| US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
| US7998744B2 (en) | 2008-07-28 | 2011-08-16 | Greenwood Genetic Center, Inc. | Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders |
| US8673574B2 (en) | 2008-08-21 | 2014-03-18 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
| NZ610356A (en) | 2008-08-28 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US9057735B2 (en) | 2008-08-29 | 2015-06-16 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US8501489B2 (en) | 2008-09-26 | 2013-08-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Urinary biomarkers to predict long-term dialysis |
| CA2740134C (en) | 2008-10-14 | 2021-10-26 | National Research Council Of Canada | Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| NZ628843A (en) | 2008-10-21 | 2016-02-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CN104020284B (zh) | 2008-10-21 | 2016-08-24 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| EP2913676A1 (en) | 2008-11-10 | 2015-09-02 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA2751435A1 (en) | 2009-02-06 | 2010-08-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and failure |
| AU2010230855A1 (en) | 2009-04-03 | 2012-01-12 | Vegenics Limited | Anti-VEGF-D antibodies |
| EP2427494B1 (en) | 2009-05-08 | 2017-10-18 | Novartis AG | Methods of modulating fibrosis using bone morphogenetic protein-9 (bmp-9) modulators |
| EP2462443A4 (en) | 2009-08-07 | 2013-01-30 | Rules Based Medicine Inc | METHODS AND DEVICES FOR DETECTING GLOMERULONEPHRITH AND ASSOCIATED DISORDERS |
| CN102792161B (zh) | 2009-08-28 | 2014-11-12 | 阿斯图特医药公司 | 肾损伤和肾衰竭的诊断及预后的方法及组合物 |
| NZ599105A (en) | 2009-09-21 | 2014-08-29 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JP5763098B2 (ja) * | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| DK2666872T3 (en) * | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
| US20130035290A1 (en) | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
| CA3158996C (en) * | 2013-01-17 | 2024-06-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
-
2011
- 2011-02-04 DK DK13177829.2T patent/DK2666872T3/en active
- 2011-02-04 ES ES13177829.2T patent/ES2585184T3/es active Active
- 2011-02-04 MX MX2016010109A patent/MX366653B/es unknown
- 2011-02-04 WO PCT/US2011/023830 patent/WO2011097539A1/en not_active Ceased
- 2011-02-04 CN CN201510522677.6A patent/CN105158481A/zh active Pending
- 2011-02-04 CN CN201180013356.3A patent/CN102791885B/zh active Active
- 2011-02-04 CA CA2788826A patent/CA2788826C/en active Active
- 2011-02-04 BR BR112012019542A patent/BR112012019542A2/pt not_active Application Discontinuation
- 2011-02-04 JP JP2012552128A patent/JP2013519095A/ja active Pending
- 2011-02-04 HU HUE13177829A patent/HUE029304T2/en unknown
- 2011-02-04 NZ NZ601590A patent/NZ601590A/en not_active IP Right Cessation
- 2011-02-04 EP EP11740468.1A patent/EP2531620B1/en not_active Not-in-force
- 2011-02-04 AU AU2011213684A patent/AU2011213684B2/en active Active
- 2011-02-04 KR KR1020127021086A patent/KR101940014B1/ko active Active
- 2011-02-04 NZ NZ700695A patent/NZ700695A/en not_active IP Right Cessation
- 2011-02-04 SI SI201130869A patent/SI2666872T1/sl unknown
- 2011-02-04 EP EP13177829.2A patent/EP2666872B1/en active Active
- 2011-02-04 MX MX2012008956A patent/MX341191B/es active IP Right Grant
- 2011-02-04 US US13/577,242 patent/US11454635B2/en active Active
- 2011-02-04 PT PT131778292T patent/PT2666872T/pt unknown
- 2011-02-04 RS RS20160473A patent/RS54879B1/sr unknown
- 2011-02-04 PL PL13177829.2T patent/PL2666872T3/pl unknown
- 2011-02-04 EA EA201290629A patent/EA201290629A1/ru unknown
-
2016
- 2016-01-15 HK HK16100466.7A patent/HK1212764A1/zh unknown
- 2016-06-24 HR HRP20160733TT patent/HRP20160733T1/hr unknown
- 2016-07-14 CY CY20161100682T patent/CY1117784T1/el unknown
- 2016-07-26 SM SM201600245T patent/SMT201600245B/it unknown
- 2016-11-30 JP JP2016232017A patent/JP6363154B2/ja not_active Expired - Fee Related
-
2018
- 2018-06-27 JP JP2018121959A patent/JP2018185320A/ja not_active Ceased
-
2022
- 2022-09-26 US US17/935,294 patent/US20230194552A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2539712A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| PL2666872T3 (pl) | Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek | |
| EP2480882A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL LESIONS AND FAILURES | |
| PT2748605T (pt) | Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal | |
| EP2394166A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF NURSE LUNGION AND NIERIN INSUFFICIENCY | |
| EP2788759A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
| EP2470905A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2364444A4 (en) | METHOD AND COMPOSITIONS FOR THE DIAGNOSIS AND FORECASTING KIDNEY INJURY AND KIDNEY FAILURES | |
| EP2361018A4 (en) | METHOD AND COMPOSITIONS FOR THE DIAGNOSIS AND FORECASTING KIDNEY INJURY AND KIDNEY FAILURES | |
| EP2324354A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL INSUFFICIENCY | |
| EP2347260A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2324355A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2364370A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY OR RENAL INSUFFICIENCY | |
| EP2625524A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
| EP2393937A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2496258A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
| EP3734280B8 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2462440A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP3077819A4 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP3004873A4 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2721404A4 (en) | DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2393934A4 (en) | DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2496942A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | |
| EP2462446A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency | |
| EP2729803A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE |